C07D

Heterocyclic Compounds (Drug Molecules)

EPO Patent Bulletin

← All categories
Filter: All Correction Grant Limitation Publication Search Report

131 items

(filtered)
Grant

Salts Of 2 Bromolysergic Acid Diethylamide

EP4630418B1 · Mar 18, 2026
Grant

Compound, Light Emitting Element, Display Device, And Lighting Device

EP4559914B1 · Mar 18, 2026
Grant

Heterocyclic Compounds As Modulators Of Bcl6 As Ligand Directed Degraders

EP4514473B1 · Mar 18, 2026
Grant

Precursors For The Controlled Release Of Alpha, Beta Unsaturated Aldehydes Or Ketones And Other High Impact Fragrance Substances

EP4373805B1 · Mar 18, 2026
Grant

Process For The Recovery Of Epsilon Caprolactam From Polyamide 6 Comprising Fishing Nets

EP4469433B1 · Mar 18, 2026
Grant

Tetrahydropyranopyrazole Derivatives For The Treatment Of Cancer And Viral Infections

EP4469461B1 · Mar 18, 2026
Grant

Molecular Sensors, Method And Kit For The Detection And Quantification Of Carbon Dioxide

EP4465883B1 · Mar 18, 2026
Grant

Deuterated Or Partially Deuterated N,N Dimethyltryptamine Compounds

EP4275753B1 · Mar 18, 2026
Grant

Non Aqueous Electrolyte Solution For Lithium Secondary Battery And Lithium Secondary Battery Including The Same

EP4258408B1 · Mar 18, 2026
Grant

Pyrrolo[2,1 F][1,2,4]Triazines Derivatives As Inhibitors Of Dyrk1 A

EP4415816B1 · Mar 18, 2026
Grant

Method For Producing Carbonyl Halide

EP4292708B1 · Mar 18, 2026
Grant

Fragrance Substances And Formulation Containing Them

EP4433483B1 · Mar 18, 2026
Grant

Urea Derivatives Which Can Be Used To Treat Cancer

EP4334298B1 · Mar 18, 2026
Grant

Triazine Derivatives For The Treatment Of Tumours And Neurodegenerative Disorders

EP4359391B1 · Mar 18, 2026
Grant

Positive Electrode Active Material, Positive Electrode And Lithium Secondary Battery Including The Same

EP4199179B1 · Mar 18, 2026
Grant

Nlrp3 Inhibitors

EP4337652B1 · Mar 18, 2026
Grant

Antiviral Prodrugs And Nanoformulations Thereof

EP4234561B1 · Mar 18, 2026
Grant

Small Molecule Urea Derivatives As Sting Antagonists

EP4384268B1 · Mar 18, 2026
Grant

3 Hydroxyadipic Acid 3,6 Lactone Composition

EP4306515B1 · Mar 18, 2026
Grant

N Alkyl O Aryl Carbamates Of 6 H Dibenzo[]B,D]Pyran 3,8 Diols As Mitophagy Enhancers

EP4330245B1 · Mar 18, 2026
Grant

New Contrast Agent For Use In Magnetic Resonance Imaging

EP4308551B1 · Mar 18, 2026
Grant

Method For Preparing An Enantiomerically Enriched Form Of 3 (2 Chlorothiazol 5 Yl) 8 Methyl 7 Oxo 6 Phenyl 2,3 Dihydrothiazolo[3,2 A]Pyrimidin 4 Ium 5 Olate

EP4281462B1 · Mar 18, 2026
Grant

Method For Preparing An Enantiomerically Enriched Form Of 3 (2 Chlorothiazol 5 Yl) 8 Methyl 7 Oxo 6 Phenyl 2,3 Dihydrothiazolo[3,2 A]Pyrimidin 4 Ium 5 Olate

EP4281461B1 · Mar 18, 2026
Grant

Pyridazine Compounds For Inhibiting Nlrp3

EP4320102B1 · Mar 18, 2026
Grant

Khk Inhibitors

EP4313967B1 · Mar 18, 2026
Grant

Quinoxaline Derivatives And Uses Thereof

EP4288426B1 · Mar 18, 2026
Grant

Heteroaromatic Spermidine Analogues And Their Anticancer Activity

EP4288422B1 · Mar 18, 2026
Grant

Methods Of Iron Catalyzed C H Bond Amination

EP4140974B1 · Mar 18, 2026
Grant

Materials For Electronic Devices

EP4037000B1 · Mar 18, 2026
Grant

N [4 (6 Fluoro 3,4 Dihydro 2(1 H) Isoquinolinyl) 2,6 Dimethylphenyl] 1 Methyl Cyclopropane Acetamide, A Potassium Channel Regulator For The Treatment Of Epilepsy

EP4074696B1 · Mar 18, 2026
Grant

Compounds For Prevention Or Treatment Of Neurodegenerative Disorders

EP4200299B1 · Mar 18, 2026
Grant

Aniline Compound Used As Rory Regulator

EP4151626B1 · Mar 18, 2026
Grant

Immunomodulator

EP4177249B1 · Mar 18, 2026
Grant

Modulators Of G Protein Coupled Receptor 88

EP4263492B1 · Mar 18, 2026
Grant

Organic Electroluminescent Element

EP4174062B1 · Mar 18, 2026
Grant

Compounds And Compositions As Sppl2 A Inhibitors

EP4214210B1 · Mar 18, 2026
Grant

Substituted Pyridazinone Herbicides

EP4267556B1 · Mar 18, 2026
Grant

Process For The Synthesis Of Cannabidiol And Intermediates Thereof

EP3923917B1 · Mar 18, 2026
Grant

Organic Compound Of Formula (I) For Use In Organic Electronic Devices, An Organic Electronic Device Comprising A Compound Of Formula (I) And A Display Device Comprising The Organic Electronic Device

EP4169086B1 · Mar 18, 2026
Grant

Preparation Of Substituted 4 (N' Hydroxycarbamimidoyl)benzoic Acids

EP4157824B1 · Mar 18, 2026
Grant

Compounds Useful For Inhibiting Ret Kinase

EP4143184B1 · Mar 18, 2026
Grant

Modulators Of Complex I

EP4291552B1 · Mar 18, 2026
Grant

2 Aminoquinazolinone Derivatives As Methionine Adenosyltransferase 2 A Inhibitors

EP4165040B1 · Mar 18, 2026
Grant

Brm Targeting Compounds And Associated Methods Of Use

EP4161935B1 · Mar 18, 2026
Grant

Method For Obtaining Biosourced Polyepoxides With Improved Properties

EP4172161B1 · Mar 18, 2026
Grant

Crystalline Form Of Jak Inhibitor And Application Thereof

EP4108664B1 · Mar 18, 2026
Grant

Isoquiniline Nrf2 Agonists

EP4139295B1 · Mar 18, 2026
Grant

Isoquiniline Nrf2 Agonists

EP4139294B1 · Mar 18, 2026
Grant

Process For Preparing A Cot Inhibitor Compound

EP4126862B1 · Mar 18, 2026
Grant

Alkyl Amine Harmine Derivatives For Promoting Bone Growth

EP3915987B1 · Mar 18, 2026
Grant

A Nebulizer Comprising A Pharmaceutical Composition Comprising 2' Substituted Carba Nucleoside Analogs For Antiviral Treatment

EP3932931B1 · Mar 18, 2026
Grant

Dihydro 2 Pyrrolo[3,4 C]Pyridine Derivatives As Gabaa A5 Receptor Modulators

EP4126858B1 · Mar 18, 2026
Grant

Substituted Vinyl Piperazine Piperidine Urea Derivatives As Anticancer Agents

EP4163273B1 · Mar 18, 2026
Grant

Novel Adamantane Derivatives As Inhibitors Of Focal Adhesion Kinase

EP4074697B1 · Mar 18, 2026
Grant

Cd4 Mimic Compound With Anti Hiv Activity

EP4052726B1 · Mar 18, 2026
Grant

Heterocyclic Compound And Organic Light Emitting Device Comprising Same

EP4050001B1 · Mar 18, 2026
Grant

Long Acting Low Addiction Hnk Derivative And Preparation Method Therefor

EP4148048B1 · Mar 18, 2026
Grant

Pharmaceutical Composition Containing Nitroxoline, Nitroxoline Tablet, Preparation Method Therefor And Use Thereof

EP4085902B1 · Mar 18, 2026
Grant

Process For Producing Functionalized Polythiophenes

EP4151640B1 · Mar 18, 2026
Grant

Heterocyclic Compound

EP4046688B1 · Mar 18, 2026
Grant

Organic Thin Film, Method For Producing Organic Thin Film, Organic Electroluminescent Element, Display Device, Lighting Device, Organic Thin Film Solar Cell, Thin Film Transistor, Photoelectric Conversion Element, Coating Composition And Material For Organic Electroluminescent Elements

EP4026836B1 · Mar 18, 2026
Grant

Imidazopyridine Derivative And Pharmaceutical Composition Comprising Same As Active Ingredient

EP4023647B1 · Mar 18, 2026
Grant

Crystalline Form Of Dimethylamino Micheliolide Fumarate Monohydrate

EP4071143B1 · Mar 18, 2026
Grant

Antimalarial Agents

EP4061375B1 · Mar 18, 2026
Grant

Preparation Of Trifarotene And Intermediates And Polymorphs Thereof

EP4073035B1 · Mar 18, 2026
Grant

Synthesis Of Amanin And Its Derivatives

EP4077353B1 · Mar 18, 2026
Grant

Heterocyclic Compound, Organic Light Emitting Diode Comprising Same, Composition For Organic Layer Of Organic Light Emitting Diode, And Method For Manufacturing Organic Light Emitting Diode

EP4043454B1 · Mar 18, 2026
Grant

Iso Citrate Dehydrogenase (Idh) Inhibitor

EP4041732B1 · Mar 18, 2026
Grant

Drug Combinations Of Entecavir And A Tlr7 Agonist For Use In The Treatment Of Hbv

EP4029503B1 · Mar 18, 2026
Grant

Crystalline Forms Of A Capsid Protein Assembly Inhibitor Containing A Pyrrole Ring, And Application Thereof

EP4036078B1 · Mar 18, 2026
Grant

Pyridopyrimidine Derivatives Useful As Kras G12 C And Kras G12 D Inhibitors In The Treatment Of Cancer

EP4048671B1 · Mar 18, 2026
Grant

Non Lysosomal Glucosylceramidase Inhibitors And Uses Thereof

EP3966199B1 · Mar 18, 2026
Grant

Gem Disubstituted Heterocyclic Compounds And Their Use As Idh Inhibitors

EP4055015B1 · Mar 18, 2026
Grant

Bicyclic Nitrogen Containing Heterocycles As Inhibitors Of Salt Induced Kinase Sik2

EP4051677B1 · Mar 18, 2026
Grant

Prodrugs Of Monomethyl Fumarate

EP3956287B1 · Mar 18, 2026
Grant

Cell Activator Of Animal Cell

EP3960244B1 · Mar 18, 2026
Grant

Phenazine Derivative And Use Thereof For The Treatment Of Cancer

EP4007639B1 · Mar 18, 2026
Grant

Pyrrolopyrazole Derivative

EP3936192B1 · Mar 18, 2026
Grant

Compounds For Electronic Devices

EP4078692B1 · Mar 18, 2026
Grant

2 Phenoxy Pyrimidine Derivatives As Herbicidal Compounds

EP4010323B1 · Mar 18, 2026
Grant

Isoquinoline Derivatives And Their Use For The Treatment Of Parasitic Infections

EP4003524B1 · Mar 18, 2026
Grant

Phosphatidylinositol 3 Kinase Inhibitors

EP3952870B1 · Mar 18, 2026
Grant

Preparation Method For Amide Compounds And Use Thereof In Medical Field

EP3950682B1 · Mar 18, 2026
Grant

Synthesis Of Coelenterazine

EP3966214B1 · Mar 18, 2026
Grant

4 [[2 [[5 [1 (1 H Indol 2 Yl) 2 (Phenyl) 1 Ethen 1 Yl] 2 Pyridinyl]Oxy]Ethyl]Amino] 2 Butenamide Derivatives For The Treatment Of Estrogen Receptor Positive Breast Cancer

EP3889133B1 · Mar 18, 2026
Grant

Integrated Methods And Systems For Producing Amide And Nitrile Compounds

EP3935041B1 · Mar 18, 2026
Grant

Pyrazine Derivative As Chk1 Inhibitor

EP3811944B1 · Mar 18, 2026
Grant

Tetrahydro Pyrido[3,4 B]Indole Estrogen Receptor Modulators And Uses Thereof

EP3760623B1 · Mar 18, 2026
Grant

Preparation Of 2 Substituted 4 Methyl Tetrahydropyrans Of 2 Substituted 4 Hydroxy 4 Methyl Tetrahydropyrans As Starting Materials

EP3873888B1 · Mar 18, 2026
Grant

Dihydropyran Derivatives And Use Thereof As Fragrance

EP3867338B1 · Mar 18, 2026
Grant

Antagonists Of Human Integrin (Alpha4)(Beta7)

EP3773573B1 · Mar 18, 2026
Grant

Compounds And Uses Thereof

EP3768269B1 · Mar 18, 2026
Grant

Receptor Inhibitor, Pharmaceutical Composition Comprising Same, And Use Thereof

EP3770148B1 · Mar 18, 2026
Grant

Deuterated Compounds As Rock Inhibitors

EP3768661B1 · Mar 18, 2026
Grant

Organic Compounds

EP3768254B1 · Mar 18, 2026
Grant

Antibacterial Agents: O Alkyl Deuterated Pyronins

EP3752143B1 · Mar 18, 2026
Grant

Cyanoaryl Aniline Compounds For Treatment Of Dermal Disorders

EP3883552B1 · Mar 18, 2026
Grant

Novel Compounds For The Treatment Of Respiratory Diseases

EP3877382B1 · Mar 18, 2026
Grant

Solvent Free Cross Coupling Reaction, And Production Method Using Said Reaction

EP3872055B1 · Mar 18, 2026
Grant

Substituted Heterocycle Fused Gamma Carbolines Synthesis

EP3609891B1 · Mar 18, 2026
Grant

Oxazole And Oxadiazole Derivatives Useful As Agonists Of Free Fatty Acid Receptor 1

EP3956323B1 · Mar 18, 2026
Grant

Factor Xiia Inhibitors

EP3788039B1 · Mar 18, 2026
Grant

Bioispired Proteasome Activators With Antiageing Activity

EP3761950B1 · Mar 18, 2026
Grant

2 Cyanopyrimidin 4 Yl Carbamate Or Urea Derivative Or Salt Thereof, And Pharmaceutical Composition Including Same

EP3778576B1 · Mar 18, 2026
Grant

Synthesis Of Coelenterazine

EP3830088B1 · Mar 18, 2026
Grant

Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Diseases

EP3806853B1 · Mar 18, 2026
Grant

Method For Producing Dihydroxyindoles

EP3689852B1 · Mar 18, 2026
Grant

Anti Inflammatory, Anti Cancer, And Anti Angiogenic Compounds, Pharmaceutical Compositions, And Methods Of Making And Using Thereof

EP3687972B1 · Mar 18, 2026
Grant

Crystal Form And Salt Of 3 (3,5 Dichloro 4 Hydroxybenzoyl) 1,1 Dioxo 2,3 Dihydro 1,3 Benzothiazole

EP3617199B1 · Mar 18, 2026
Grant

15 Idene 14 Deoxy 11,12 Dehydroandrographolide Derivative And Application Thereof In Preparing Anti Fibrosis Drugs

EP3608313B1 · Mar 18, 2026
Grant

Edaravone For Treating Amyotrophic Lateral Sclerosis Or Preventing Progression Of Phase Of Amyotrophic Lateral Sclerosis

EP3520788B1 · Mar 18, 2026
Grant

Novel Modulators Of The Sigma 2 Receptor And Their Method Of Use

EP3600290B1 · Mar 18, 2026
Grant

Continuous Dilution Of Polyisocyanates

EP3649113B1 · Mar 18, 2026
Grant

Anticancer Compounds

EP3612172B1 · Mar 18, 2026
Grant

Isoxazole N Linked Carbamoyl Cyclohexyl Acids As Lpa Antagonists

EP3728210B1 · Mar 18, 2026
Grant

Compound, Coating Composition Comprising Same, And Organic Light Emitting Element Comprising Same

EP3578553B1 · Mar 18, 2026
Grant

Deuterated Derivatives Of Ruxolitinib

EP3450434B1 · Mar 18, 2026
Grant

Aryl And Heteroaryl Ether Derivatives As Liver X Receptor Beta Agonists

EP3526196B1 · Mar 18, 2026
Grant

Chemical Compounds As Antibiotics

EP3601224B1 · Mar 18, 2026
Grant

Processes For Preparing Acc Inhibitors And Solid Forms Thereof

EP3589636B1 · Mar 18, 2026
Grant

Substituted Pyrazolopyrimidinone Compounds As Pde2 Inhibitors

EP3562828B1 · Mar 18, 2026
Grant

Particulate Nucleating Agent And Method For Manufacturing Thereof

EP3362509B1 · Mar 18, 2026
Grant

Ion Channel Inhibitory Compounds, Pharmaceutical Formulations And Uses

EP3340988B1 · Mar 18, 2026
Grant

Piperazinyl Norbenzomorphan Compounds And Methods For Using The Same

EP3364976B1 · Mar 18, 2026
Grant

Processable Polymers And Methods Of Making And Using Thereof

EP3322710B1 · Mar 18, 2026
Grant

Estrogen Receptor Modulators

EP3442971B1 · Mar 18, 2026
Grant

Vortioxetine Pamoic Acid Salt And Crystal Form Thereof

EP3438099B1 · Mar 18, 2026
Grant

Solid Forms Of A Thienopyrimidinedione Acc Inhibitor And Methods For Production Thereof

EP3423456B1 · Mar 18, 2026
Grant

Adenine Derivatives As Protein Kinase Inhibitors

EP3452477B1 · Mar 18, 2026
Grant

Folate Receptor Binding Conjugates Of Antifolates

EP2349274B1 · Mar 18, 2026
Grant

Composition And Organic Optoelectric Device And Display Device

EP2821459B1 · Mar 18, 2026